ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 1696 - 1710 of 5996 products
Bio-Thera Files for Approval of Avastin Biosimilar in Europe
$5.00
Available
PreGene Closes $21 Million Financing for Fusion/Nano-Antibody Drugs
$5.00
Available
CHHT-Alvotech JV Signs China Deal to Commercialize Biosimilars
$5.00
Available
Eluminex, a Suzhou Startup, Closes $50 Million Round for Ophthalmic Drugs
$5.00
Available
Beijing Gene+ Raises $38 Million for Cancer Diagnostics
$5.00
Available
Ascentage to Start China Trials of Bcl-2 Apoptosis Candidate
$5.00
Available
Antengene Completes $340 Million Hong Kong IPO for Oncology Drugs
$5.00
Available
RecBio Raises $227 Million for Novel Genetically Engineered Vaccines
$5.00
Available
Alphamab and 3D Medicines File China NDA for PD-L1 Therapy
$5.00
Available
Newsoara Forms $135 Million Novel Drug Deal with AUM Bio
$5.00
Available
BeiGene Plans to Raise up to $2.5 Billion in Shanghai Star IPO
$5.00
Available
GeneScience Acquires Rights to Prostate Cancer Therapy in $132 Million Agreement
$5.00
Available
WuXi Biortus Raises $15 Million for Cryo-EM Drug Discovery CRO
$5.00
Available
Innovent Bio Reports Novel Bi-Specific is Effective in AMD Trial
$5.00
Available
Zhimeng Biopharma Closes $35 Million Funding for Trials of HBV Therapy
$5.00
Available